C9080

Monoklonales Anti-Vimentin

clone V9, purified immunoglobulin, buffered aqueous solution

• Synonym(e): Monoclonal Anti-Vimentin
• NACRES: NA.41
• UNSPSC Code: 12352203
• Conjugate: CY3 conjugate
• Clone: V9, monoclonal
• Application: IF (d), IHC (f), IHC (p)
• Citations: 33

Eigenschaften

• biological source: mouse
• Quality Level: 200
• conjugate: CY3 conjugate
• antibody form: purified immunoglobulin
• antibody product type: primary antibodies
• clone: V9, monoclonal
• form: buffered aqueous solution
• mol wt: antigen ~58 kDa
• species reactivity: pig, canine, feline, hamster, rabbit, gerbil, monkey, bovine, chicken, human, horse, rat
• technique(s): direct immunofluorescence: 1:200 using cultured cells, immunohistochemistry (formalin-fixed, paraffin-embedded sections): 1:50 using human tonsil, immunohistochemistry (frozen sections): suitable using human tonsil

Beschreibung

General description

Monoclonal Anti-Vimentin (mouse IgG1 isotype) is derived from the hybridoma produced by the fusion of mouse myeloma cells and splenocytes from immunized BALB/c mice. Vimentin is expressed in breast myoepithelial cells, osteocytes, Langerhans cells of the skin, Schwann cells and astrocytes.

Vimentin is one of the five major groups of intermediate filaments with a molecular mass of 57 kDa. Intermediate filaments (IFs) with characteristic 10 nm diameter are a distinct class of molecularly heterogenous cytoskeletal filaments defined by ultrastructural, immunological and biochemical criteria. IFs differ significantly from the other cytoskeletal elements of the cell, namely microtubules and microfilaments and are components of most eukaryotic cells.

Immunogen

Vimentin aus Schweineaugenlinsen.

Application

Monoclonal Anti-Vimentin-Cy3 antibody produced in mouse has been used in:

• immunofluorescence and confocal microscopy
• cytoskeleton staining
• double labeling experiments
• immunohistochemical
• immunocytochemical localozation

Biochem/physiol Actions

In der immunhistochemischen Färbung wird Vimentin vom Antikörper in Fibroblasten, Endothelzellen, lymphoidem Gewebe und Melanozyten lokalisiert. Außerdem färbt der Antikörper Vimentin in Sarkomen, Lymphomen und Melanomen.

Cy3 Monoclonal Anti-Vimentin reacts with normal and pathological tissue of mesenchymally-derived cells, lens tissue and various cultured cells. It localizes vimentin in fibroblasts, lipocytes, endothelial cells, some lymphoid cells, melanocytes, macrophages, and chondrocytes. The antibody stains tumors derived from these cells, including sarcomas, most lymphomas, melanomas and their metastatic lesions. Co-expression of vimentin with keratin was described in most carcinomas of certain sites (e.g., kidney and thyroid) and certain carcinomas of other sites (e.g., breast).

Vimentin was found to be important for stabilizing the architecture of the cytoplasm. It was found, that activated macrophages secrete vimentin into the extracellular space in vitro.

Physical form

Solution in 0.01 M phosphate buffered saline, pH 7.4, containing 1% bovine serum albumin and 15 mM sodium azide

Preparation Note

Store at 2-8 °C. Protect from prolonged exposure to light. If slight turbidity occurs upon prolonged storage, clarify the solution by centrifugation before use.

Legal Information

Cy is distributed under license from Amersham Biosciences Limited.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Sicherheitshinweise

• Lagerklasse: 10 - Combustible liquids
• wgk: nwg
• flash_point_f: Not applicable
• flash_point_c: Not applicable
• ppe: Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)